Correlation Between NeuroSense Therapeutics and Celularity
Can any of the company-specific risk be diversified away by investing in both NeuroSense Therapeutics and Celularity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuroSense Therapeutics and Celularity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NeuroSense Therapeutics Ltd and Celularity, you can compare the effects of market volatilities on NeuroSense Therapeutics and Celularity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuroSense Therapeutics with a short position of Celularity. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuroSense Therapeutics and Celularity.
Diversification Opportunities for NeuroSense Therapeutics and Celularity
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between NeuroSense and Celularity is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding NeuroSense Therapeutics Ltd and Celularity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celularity and NeuroSense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuroSense Therapeutics Ltd are associated (or correlated) with Celularity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celularity has no effect on the direction of NeuroSense Therapeutics i.e., NeuroSense Therapeutics and Celularity go up and down completely randomly.
Pair Corralation between NeuroSense Therapeutics and Celularity
Assuming the 90 days horizon NeuroSense Therapeutics is expected to generate 1.21 times less return on investment than Celularity. But when comparing it to its historical volatility, NeuroSense Therapeutics Ltd is 1.1 times less risky than Celularity. It trades about 0.1 of its potential returns per unit of risk. Celularity is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 7.28 in Celularity on November 2, 2024 and sell it today you would lose (0.68) from holding Celularity or give up 9.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 89.38% |
| Values | Daily Returns |
NeuroSense Therapeutics Ltd vs. Celularity
Performance |
| Timeline |
| NeuroSense Therapeutics |
| Celularity |
NeuroSense Therapeutics and Celularity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NeuroSense Therapeutics and Celularity
The main advantage of trading using opposite NeuroSense Therapeutics and Celularity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuroSense Therapeutics position performs unexpectedly, Celularity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celularity will offset losses from the drop in Celularity's long position.| NeuroSense Therapeutics vs. Neurosense Therapeutics | NeuroSense Therapeutics vs. GeoVax Labs | NeuroSense Therapeutics vs. NLS Pharmaceutics AG | NeuroSense Therapeutics vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance |